Aston Martin cuts 2025 guidance as Q3 volumes slip and EBIT disappoints
Aston Martin Lagonda has lowered its full-year 2025 outlook after a softer third quarter. Wholesale volumes and margins have come under pressure, while adjusted EBIT is now expected to be worse than the already negative market consensus. The headline positives are a capex trim, solid liquidity after a stake sale, and the long-awaited Valhalla starting deliveries in Q4. But external risks – tariffs, taxes and homologation timing – are doing a lot of the driving.
Key numbers from the trading update
| Item | Update | Reference |
|---|---|---|
| Q3 2025 wholesale units | c. 1,430 | Q3 2024: 1,641; prior guidance was broadly similar to prior year |
| FY 2025 wholesales | Decline by mid-to-high single digit percentage | FY 2024: 6,030 |
| Valhalla deliveries in Q4 2025 | c. 150 units | Behind prior expectations; smooth profile expected in 2026 |
| Adjusted EBIT FY 2025 | Below lower end of consensus | Consensus low end: £(110)m |
| H2 2025 free cash flow | No longer expected to be positive | Previously guided positive |
| FY 2025 capex | c. £375m | Previous guidance c. £400m |
| FY 2025 SG&A | Down c. 10% | FY 2024: £313m |
| Liquidity at Q3 end | c. £250m | Includes c. £108m gross proceeds from AMR GP share sale |
Q3 2025 performance – weaker demand and a tougher mix
Aston Martin delivered around 1,430 wholesale units in Q3, missing its guidance for a broadly similar outcome to last year’s 1,641. Management points to softer demand in North America – where tariffs are biting – and across APAC, including Greater China. Retail volumes were in line with wholesales, which suggests the company is keeping dealer inventories in check.
Margins are set to reflect a “negative mix” from fewer Special deliveries. For context, Special cars tend to carry higher average selling prices and better margins, so fewer of them depresses profitability even if unit volumes hold up.
Revised FY 2025 outlook – volumes cut, EBIT below consensus, FCF pulled
The company now expects total wholesales in 2025 to fall by a mid-to-high single digit percentage versus 2024’s 6,030 units. In plain English, that implies a few hundred fewer cars than last year, with most of the reduction coming from North America and APAC. The stance is deliberate too – Aston Martin says it will keep balancing wholesales to dealer demand, rather than push volume into the channel.
Adjusted EBIT for 2025 is now guided to be below the lower end of market consensus, which the company quotes at £(110)m. That is a clear downgrade and, coupled with softer gross margin per vehicle, it is the key negative in this update. Free cash flow, previously expected to be positive in H2, is now guided to be not positive, although management still expects sequential improvement in Q4.
Product cadence – Valhalla starts, new S-derivatives land
There is progress on the product side. The new Vanquish Volante began customer deliveries in Q3. Q4 should see deliveries of the new Vantage S and DBX S, with the latter receiving exceptional initial media reviews according to the company.
Valhalla entered production in Q3. Initial customer deliveries remain slated for Q4, but on a marginally delayed timeline to complete vehicle engineering and finalise mandatory homologation approvals. As a result, Q4 Valhalla wholesales are now expected to be about 150 units. Management expects a smoother delivery profile through 2026.
Note the explicit risks here: the current U.S. federal government shutdown could impact the timing of final U.S. homologation, and the U.S. tariff quota system remains a moving target. Either could shift delivery timing and mix.
Costs, capex and liquidity – tightening the belt without stalling the plan
On the financial levers, capex for 2025 is now expected at about £375m, down from £400m. SG&A is still on track to decline by roughly 10% versus 2024’s £313m. Management has also kicked off an immediate review of future costs and capital expenditure, including the product cycle plan, responding to market and regulatory dynamics.
Importantly, the company says it now expects lower capital investment in engineering and development than previously guided for 2025-2029, where prior guidance sat at around £2bn. The exact new figure is not disclosed.
Liquidity looks supported in the near term. Aston Martin completed the sale of shares in AMR GP in Q3, bringing in roughly £108m in gross proceeds. Period-end liquidity stood at around £250m.
Macro and regulatory headwinds – tariffs, taxes and supply chain risk
The update underscores a tough backdrop for UK manufacturers. There is ongoing uncertainty from U.S. tariffs and the new quota mechanism, changes to ultra-luxury car taxes in China, and a higher chance of supply chain disruption following a recent cyber incident at a major UK automaker. The company flags that the U.S. tariff quota mechanism adds complexity to forecasting into year-end and potentially quarter by quarter from 2026.
Aston Martin says it is engaging with both U.S. and UK governments. Dialogue with the U.S. side is described as positive, while the company is seeking more proactive support from the UK government for small-volume manufacturers.
What this means for investors
This reads like a classic profit warning, even if the product story is moving forward. The downgrade to volumes, EBIT below the consensus low end, and the withdrawal of positive H2 free cash flow are the clear negatives. That said, the company is acting on costs and capex, liquidity is intact, and 2026 is guided to be materially better as Valhalla contributes more consistently and SG&A reductions flow through.
- Negatives: Q3 miss, softer demand in North America and APAC, fewer high-margin Special deliveries, adjusted EBIT now worse than £(110)m, and H2 FCF no longer positive. Execution risk remains on Valhalla homologation and U.S. tariff quotas.
- Positives: New models hitting the market, capex trimmed to c. £375m, SG&A trending down about 10%, liquidity at c. £250m boosted by the c. £108m AMR GP proceeds, and a stated path to improved profitability and free cash in 2026.
The strategic choice to prioritise disciplined wholesales over pushing inventory into dealers is sensible for brand equity and long-term pricing power. But it does mean near-term revenue and margin pressure when retail demand softens.
Key things to watch into Q4 and the 29 October results
- Homologation milestones – confirmation of U.S. approvals and any impact from the government shutdown.
- Valhalla delivery cadence – whether c. 150 units land in Q4 and how the mix supports margins.
- Order intake and reviews – early demand signals for Vantage S and DBX S, and the balance of wholesales to retail.
- Tariff and quota clarity – any update from U.S. engagement and implications for 2026 forecasting.
- Cash trajectory – detail on working capital and how sequential free cash flow improvement shapes up in Q4.
- Cost and capex review – specifics on the revised product cycle plan and lower 2025-2029 engineering spend.
My take
It is a tough update, driven largely by external shocks and a cautious wholesale stance. The Valhalla launch and S-derivative pipeline offer a credible lever for mix and margin, but execution and the policy backdrop will dictate the pace of recovery. The 2026 uplift is plausible if deliveries normalise and cost actions stick – investors will want firmer evidence of that bridge in the Q3 results and into early 2026.
